Khan Samina - Insider Non-Derivative Transactions at REATA PHARMACEUTICALS INC (RETA) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on May 16, 2023, Khan Samina's relationship to REATA PHARMACEUTICALS INC (RETA) is Officer (SVP, Chief Medical Officer), and currently has 39,491 shares of Class A common stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other RETA insiders.
Data Source: SEC.
Khan Samina - Insider Non-Derivative Transactions of RETA Class A common stock
Khan Samina - Insider Non-Derivative Transactions at RETA
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| May 17, 2023 | Sell -- (Class A common stock) | 352 | 81.37 | 39491 |
| May 16, 2023 | Sell -- (Class A common stock) | 288 | 85.32 | 39843 |
| Mar 8, 2023 | Sell -- (Class A common stock) | 3961 | 83.46 | 40131 |
| Mar 4, 2023 | Sell -- (Class A common stock) | 2813 | 87.36 | 44092 |
| Mar 3, 2023 | Sell -- (Class A common stock) | 2649 | 85.38 | 46905 |
| Mar 3, 2023 | Sell -- (Class A common stock) | 18956 | 85.02 | 49554 |
| Mar 3, 2023 | Sell -- (Class A common stock) | 3395 | 83.7 | 68510 |
| Mar 3, 2023 | M -- (Class A common stock) | 25000 | 27.32 | 71905 |
| Jan 4, 2023 | Acquisition -- (Class A common stock) | 11756 | 0 | 46905 |